Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share, Growth Analysis & Tren

Published: Tue Apr 23 2019

This report on the Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel anti-MRSA drug molecules, increase in prevalence of MRSA infections, and their improved screening are boosting the growth of the global MRSA drugs market. According to CDC, two in every 100 people carry MRSA. Introduction of generic drugs for the MRSA treatment, and upsurge in the consumption of antibiotics in the developing countries are some of the factors expected to drive the growth of global MRSA drugs market during the forecast period.

Click here for Free Sample Report@

The MRSA drugs market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on drug class, route of administration, distribution channel, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the report comprises epidemiological assessment of MRSA infection, in terms of causes, complications, current & future treatment options for MRSA, along with its prevalence rate in key countries. The report contains comparative analysis of key companies operating in the global MRSA drugs market, in terms of strategic developments, current and future market positioning, and their key differential parameters, to help understand the competitive landscape in the market. Moreover, the global corporate scenario is provided in the report with major pipeline products of emerging and established pharmaceutical manufacturers, and their respective dosage forms. This report also provides market attractiveness and its analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global MRSA drugs market.

View Full Report with TOC@

Based on the drug class, the global MRSA drugs market is segmented into lipopeptide, oxazolidinone, cephalosporin, tetracycline, lipoglycopeptide, folate antagonist, and others. Lipopeptide accounted for highest market share in 2016, owing to the diversified distribution of daptomycin (lipopeptide) across the globe by key distributors in 2016. Others drug class is projected to expand at relatively significant CAGR during 2017-2025, which is attributable to the rising incidence of community-acquired MRSA infection. Different types of route of administration in the MRSA drugs market are oral and parenteral. Parenteral segment dominated the market in terms of market share in 2016, and is expected to continue to lead the global market during forecast period. However, oral segment is likely to expand during 2017-2025, due to presence of numerous oral vaccines against MRSA infection in the developmental phase by key companies. Various distribution channels in the global MRSA market are hospital pharmacy, retail pharmacy, and online pharmacy. Hospital pharmacy held maximum market share in 2016, and is expected to remain dominant by 2025 in terms of revenue. However, online pharmacy is likely to expand with maximum CAGR owing to the rising adoption of the population for digital platform. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global MRSA drugs has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, Russia, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global MRSA drugs based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Basilea Pharmaceutica Ltd., The Medicines Company, Theravance Biopharma, Allergan, Merck & Co., Inc., and Pfizer, Inc.

The Global MRSA drugs Market has been segmented as given below:

Global MRSA Drugs Market, by Drug Class

  • Lipopeptide

  • Oxazolidinone

  • Tetracycline

  • Cephalosporin

  • Lipoglycopeptide

  • Folate Antagonist

  • Others

Global MRSA Drugs Market, by Route of Administration

  • Oral

  • Parenteral

Global MRSA Drugs Market, by Distribution Channel

  • Hospital Pharmacy

  • Retail Pharmacy

  • Online Pharmacy

Global MRSA drugs Market, by Region

  • North America

    • S.

    • Canada

  • Europe

    • Germany

    • K.

    • France

    • Italy

    • Spain

    • Rest of Europe

  • Asia Pacific

    • India

    • China

    • Japan

    • Rest of Asia Pacific

  • Latin America

    • Brazil

    • Mexico

    • Rest of Latin America

  • Middle East & Africa

    • GCC Countries

    • South Africa

    • Israel

    • Rest of Middle East & Africa

Enquire About This Report @

About Market Research Reports Search Engine (MRRSE)

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us

State Tower

90, State Street

Suite 700

Albany, NY - 12207

United States Telephone: +1-518-730-0559

Contact Name: MRRSE
Contact Email:

Visit website »